Long-term follow-up of residual mediastinal-hilar Ga-67 uptake after treatment for Hodgkin's and non-Hodgkin's lymphomas: What degree of Ga-67 uptake is significant?

Clinical Nuclear Medicine

Volumn 25, Issue 12, 2000, Pages 959-962

  Nikpoor, Nayer ^a   Aliabadi, Piran ^a   Diaz, Luis ^a   Mannting, Finn ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Hilus; Mediastinum; Residual Ga 67; SPECT

Indexed keywords

GALLIUM 67;

ADOLESCENT; ADULT; AGED; ARTICLE; DRUG UPTAKE; FEMALE; FOLLOW UP; HODGKIN DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDIASTINUM TUMOR; MINIMAL RESIDUAL DISEASE; NONHODGKIN LYMPHOMA; PROGNOSIS; QUANTITATIVE DIAGNOSIS; RETROSPECTIVE STUDY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SURVIVAL TIME; THORAX RADIOGRAPHY; TUMOR RECURRENCE;

FEMALE; FOLLOW-UP STUDIES; GALLIUM RADIOISOTOPES; HODGKIN DISEASE; HUMANS; LYMPHOMA, NON-HODGKIN; MALE; MEDIASTINAL NEOPLASMS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; RETROSPECTIVE STUDIES; TIME FACTORS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0033652664     PISSN: 03639762     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003072-200012000-00001     Document Type: Article

References (13)

1. Residual mass in lymphoma may not be residual disease
2. The significance of residual mediastinal abnormality on the chest radiograph following treatment for Hodgkin's disease
3. Non-Hodgkin's lymphoma: Predicting prognostic grade with MR imaging
4. Lymphoma: Monitoring tumor size and signal intensity with MR imaging
5. The role of Ga-67 scintigraphy in evaluating the results of therapy of lymphoma patients
6. Ga-67 SPECT before and after treatment of lymphoma
7. Gallium-67 imaging: A predictor of residual tumor viability and clinical outcome in patients with diffuse large-cell lymphoma
8. Validation of Gallium-67-SPECT in biopsy confirmed residual Hodgkin's disease in the mediastinum
9. Lymphoma: Predictive value of Ga-67 scintigraphy after treatment
10. Residual mass and negative gallium scintigraphy in treated lymphoma
11. Uptake of gallium-67 citrate and (2-H3) deoxyglucose in the tumor model following chemotherapy and radiotherapy
12. Single photon emission computed tomography: Quantitation of gallium citrate uptake with a differentiation of lymphoma from benign hilar uptake